RISK OF FEBRILE NEUTROPENIA AND USE OF G-CSF PRIMARY PROPHYLAXIS IN NON-HODGKIN'S LYMPHOMA PATIENTS RECEIVING R-CHOP-21

被引：0
|
作者：
Haioun, C. [1 ]
Jaeger, U. [2 ]
Lugtenburg, P. [3 ]
Pettengell, R. [4 ]
Principe, F. [5 ]
Rossi, F. [6 ]
Salar, A. [7 ]
Schwenkglenks, M. [8 ]
Verhoef, G. [9 ]
Edmundson, S. [10 ]
Bacon, P. [11 ]
机构：
[1] CHU Henri Mondor, F-94010 Creteil, France
[2] Univ Klinikum, Vienna, Austria
[3] Erasmus MC, Rotterdam, Netherlands
[4] St Georges Univ London, London, England
[5] Hosp San Joao, Oporto, Portugal
[6] Univ Milan, CTMO Fdn, OM PoMaRe IRCCS, Milan, Italy
[7] Hosp Mar IMAS, Barcelona, Spain
[8] Univ Basel Hosp, European Ctr Pharmaceut Med, CH-4031 Basel, Switzerland
[9] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[10] Amgen Ltd, Uxbridge, Middx, England
[11] ZUC, Amgen Europe GmbH, Zurich, Switzerland
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0258
引用
收藏
页码：105 / 105
页数：1
相关论文
共 50 条
  • [21] Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP
    Hisaharu Shikata
    Yoshihiro Yakushijin
    Jun Yamanouchi
    Taichi Azuma
    Masaki Yasukawa
    [J]. International Journal of Clinical Oncology, 2014, 19 : 178 - 185
  • [22] Randomized comparison of standard CHOP and biweekly CHOP with prophylactic using G-CSF in aggressive non-Hodgkin's lymphoma
    Lin, T
    Guan, ZZ
    He, YJ
    Jiang, WQ
    Liu, DG
    Su, XH
    Xu, RH
    Huang, HQ
    Ten, XY
    Li, YH
    Huang, H
    Zhou, ZM
    [J]. BLOOD, 2003, 102 (11) : 405A - 405A
  • [23] Cost-effectiveness of myeloid growth factor prophylaxis strategies for febrile neutropenia among non-Hodgkin's lymphoma patients receiving curative-intent R-CHOP chemotherapy
    Wang, Xiao Jun
    Tang, Tiffany
    Farid, Mohd
    Quek, Richard
    Tao, Miriam
    Lim, Soon Thye
    Wee, Hwee Lin
    Chan, Alexandre
    [J]. PHARMACOTHERAPY, 2015, 35 (11): : E205 - E205
  • [24] ECONOMIC MODEL OF GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) IN PRIMARY (PP) AND SECONDARY PROPHYLAXIS (SP) OF FEBRILE NEUTROPENIA (FN) IN NON-HODGKIN'S LYMPHOMA (NHL) PATIENTS UNDERGOING CHEMOTHERAPY IN FRANCE
    Perrier, L.
    Sebban, C.
    Leon, N.
    Maurel, F.
    Cohen-Nizard, S.
    De Liege, F.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A450 - A450
  • [25] Risk and timing of hospitalization for febrile neutropenia among patients receiving CHOP-like regimens for intermediate-grade non-Hodgkin's lymphoma.
    Lyman, GH
    Delgado, DJ
    [J]. BLOOD, 2002, 100 (11) : 780A - 780A
  • [26] Delivery of full dose CHOP chemotherapy to elderly patients with aggressive non-Hodgkin's lymphoma without G-CSF support
    Campbell, C
    Sawka, C
    Franssen, E
    Berinstein, NL
    [J]. LEUKEMIA & LYMPHOMA, 1999, 35 (1-2) : 119 - 127
  • [27] History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in cancer patients not receiving G-CSF prophylaxis
    Chao, C.
    Page, J. H.
    Yang, S. -J.
    Rodriguez, R.
    Huynh, J.
    Chia, V. M.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (09) : 1821 - 1829
  • [28] Dose-escalation study of CHOP with or without prophylactic G-CSF in aggressive non-Hodgkin's lymphoma
    Itoh, K
    Ohtsu, T
    Wakita, H
    Igarashi, T
    Ishizawa, K
    Onozawa, Y
    Fujii, H
    Minami, H
    Sasaki, Y
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (10) : 1241 - 1247
  • [29] Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignanciesbendamustine and G-CSF support
    Cerchione, Claudio
    De Renzo, Amalia
    Nappi, Davide
    Di Perna, Maria
    Della Pepa, Roberta
    Pugliese, Novella
    Catalano, Lucio
    Pane, Fabrizio
    Picardi, Marco
    [J]. SUPPORTIVE CARE IN CANCER, 2019, 27 (05) : 1587 - 1588
  • [30] MANAGEMENTS OF FEBRILE NEUTROPENIA AMONG NON-HODGKIN'S LYMPHOMA PATIENTS IN TAIWAN
    Lin, W. T.
    Hsiao, F. Y.
    Chiang, S. C.
    Wen, Y. W.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A618 - A618
12345